Tissue dissociation enzymes for isolating human islets for transplantation: Factors to consider in setting enzyme acceptance criteria

Transplantation

Volumn 91, Issue 2, 2011, Pages 137-145

  McCarthy, Robert C ^a   Breite, Andrew G ^a   Green, Michael L ^a   Dwulet, Francis E ^a  

^a VitaCyte LLC   (United States)

Author keywords

Biochemical characterization; Collagenase; Islet isolation; Protease; Tissue dissociation; Type 1 diabetes

Indexed keywords

COLLAGENASE; COLLAGENASE G; COLLAGENASE H; ENZYME; NEUTRAL PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; DISSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INACTIVATION; ENZYME SUBSTRATE; HUMAN; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN DOMAIN;

CLOSTRIDIUM HISTOLYTICUM; ENDOPEPTIDASES; ENZYMES; HISTOLOGICAL TECHNIQUES; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICROBIAL COLLAGENASE; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 78751643426     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ffff7d     Document Type: Article

References (89)

1. Bellin M, Barton F, Hering B, etal. Induction immunosuppression with T cell depleting antibodies facilitates long term insulin independence after islet allotransplantation in type 1 diabetes. Xenotransplantation 2009; 16: 541.
2. US Food and Drug Administration. Guidance for industry: Considerations for allogenic pancreatic islet cell products. 2009. Available at: http:// www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatory Information/Guidances/CellularandGeneTherapy/ucm182440.htm. Accessed August 23, 2010.
3. International Society for Cellular Therapy. Risk of bovine spongiform encephalopathy (BSE) in collagenase enzymes. 2007. Available at: http://www.celltherapysociety.org/files/PDF/Resources/Risk-BSE-in-Collagenase- Enzymes.pdf. Accessed August 23, 2010.
4. Brandhorst H, Friberg A, Andersson HH, et al. The importance of tryptic-like activity in purified enzyme blends for efficient islet isolation. Transplantation 2009; 87: 370.
5. Kin T, O'Gorman D, Zhai X, et al. Nonsimultaneous administration of pancreas dissociation enzymes during islet isolation. Transplantation 2009; 87: 1700.
6. Szot GL, Lee MR, Tavakol MM, et al. Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease. Transplantation 2009; 88: 753.
7. Balamurugan AN, Loganathan G, Anazawa T, et al. Improved method of human islet isolation for clinical transplantation using combination of Clostridium histolyticum neutral protease (Serva) and high proportion of intact C1 collagenase (VitaCyte). Xenotransplantation 2009; 16: 545.
8. Brandhorst H, Friberg A, Nilsson B, et al. Large-scale comparison of Liberase HI and collagenase NB1 utilized for human islet isolation. Cell Transplant 2010; 19: 3.
9. Scharp DW. Commentary. Cell Transplant 2003; 2: 299.
10. Johnson PR, White SA, London NJ. Collagenase and human islet isolation. Cell Transplantation 1996; 5: 437.
11. Kin T, Johnson PRV, Shapiro AMJ, et al. Factors influencing the colla-genase digestions phase of human islet isolation. Transplantation 2007; 83: 7.
12. Kono T. Role of collagenases and other proteolytic enzymes in the dispersal of animal tissues. Biochim Biophys Acta 1969; 178: 397.
13. Hatton MW, Berry LR, Krestynski F, et al. The role of proteolytic enzymes derived from crude bacterial collagenase in the liberation of hepatocytes from rat liver. Identification of two cell-liberating mechanisms. Eur J Biochem 1983; 137: 311.
14. Hefley TJ, Stern PH, Brand JS. Enzymatic isolation of cells from neonatal calvaria using two purified enzymes from Clostridium histolyti-cum. Exp Cell Res 1983; 149: 227.
15. Suggs W, Van Wart H, Sharefkin JB. Enzymatic harvesting of adult human saphenous vein endothelial cells: Use of a chemically defined combinationoftwo purified enzymesto attain viable cell yields equal to those attained by crude bacterial collagenase preparations. J Vasc Surg 1992; 15: 205.
16. Wolters GH, Vos-Scheperkeuter GH, van Deijnen JH, et al. An analysis of the role of collagenase and protease in the enzymatic dissociation of the rat pancreas for islet isolation. Diabetologia 1992; 35: 735.
17. Fetterhoff TJ, Cavanagh TJ, Wile KJ, et al. Human pancreatic dissociation using a purified enzyme blend. Transplant Proc 1995; 27: 3282.
18. Linetsky E, Bottino R, Lehmann R, et al. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997; 46: 1120.
19. Olack BJ, Swanson CJ, Howard TK, et al. Improved method for the isolation and purification of human islets of langerhans using Liberase enzyme blend. Hum Immunol 1999; 60: 1303.
20. Peterkofsky B. Bacterial collagenase. Methods Enzymol 1982; 82: 453.
21. Mookhtiar KA, Van Wart HE. Clostridium histolyticum collagenases: A new look at some old enzymes. Matrix Suppl 1992; 1: 116.
22. Brockman DE. Histology and fine structure. In: Beger HG, Warshaw AL, Bucheler MW, et al., eds. The pancreas, vol. 1. Malden, MA, Black-well Science 1998, pp 19.
23. Klimstra DS, Hruban RH, Pitman MB. In: Mills SE, ed. Histology for pathologists [ed. 3]. Philadelphia, PA, Lippincott Williams & Wilkins 2007, pp 723.
24. Carroll PB. Anatomy and physiologyofislets ofLangerhans. In: Ricordi C, ed. Pancreatic islet cell transplantation. Austin, TX, RGLandes 1992, pp 7.
25. Moldovan S, Brunicardi FC. Endocrine pancreas: Summary of observations generated by surgical fellows. World J Surg 2001; 25: 468.
26. Lifson N, Kramlinger KG, Mayrand RR, et al. Blood flow to the rabbit pancreas with special reference to the islets of Langerhans. Gastroenter-ology 1980; 79: 466.
27. van Deijnen JH, Hulstaert CE, Wolters GH, et al. Significance of the peri-insular extracellular matrix for islet isolation from the pancreas of rat, dog, pig, and man. Cell Tissue Res 1992; 267: 139.
28. Watanabe T, Yaegashi H, Koizumi M, et al. Changing distribution of islets in the developing human pancreas: A computer-assisted three-dimensional reconstruction study. Pancreas 1999; 18: 349.
29. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999; 8: 285.
30. Ohtani O. Three-dimensional organization of the connective tissue fibersof the human pancreas: A scanning electron microscopic study of NaOH treated-tissues. Arch Histol Jpn 1987; 50: 557.
31. Martinez-Hernadez A. Electron microscopyof the extracellular matrix: An overview. Methods Enzymol 1987; 145: 78.
32. Stendahl JC, Kaufman DB, Stupp SI. Extracellular matrix in pancreatic islets: Relevance to scaffold design and transplantation. Cell Transplant 2009; 18: 1.
33. Virtanen I, Banerjee M, Palgi J, et al. Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia 2008; 51: 1181.
34. Hughes SJ, Clark A, McShane P, et al. Characterisation of collagen VI within the islet-exocrine interfaceof the human pancreas: Implications for clinical islet isolation? Transplantation 2006; 81: 423.
35. Cross SE, Hughes SJ, Partridge CJ, et al. Collagenase penetrates human pancreatic islets following standard intraductal administration. Transplantation 2008; 86: 907.
36. Vosscheperkeuter GH, Vansuylichem PTR, Vonk MWA, et al. Histo-chemical analysis of the role of class I and class II Clostridium histolyti-cum collagenase in the degradation of rat pancreatic extracellular matrix for islet isolation. Cell Transplant 1997; 6: 403.
37. Birk DE, Bruckner P. Collagen suprastructures. Top Curr Chem 2005; 247: 185.
38. Matsushita O, Jung CM, Katayama S, et al. Gene duplication and multiplicity of collagenases in Clostridium histolyticum. J Bacteriol 1999; 181: 923.
39. Yoshihara K, Matsushita O, Minami J, et al. Cloning and nucleotide sequence analysis of the colH gene from Clostridium histolyticum encoding a collagenase and a gelatinase. J Bacteriol 1994; 176: 6489.
40. Burtscher H, Ambrosius D, Hesse F. Recombinant collagenase type I from Clostridium histolyticum and its use for isolating cells and groups of cells. 2002; US patent 6, 475, 764.
41. Ambrosius D, Hesse F, Burtscher H. Recombinant collagenase type II from Clostridium histolyticum and its use for the isolation of cellular agglomerations. 1995; EP0677586 (A1).
42. Matsushita O, Okabe A. Clostridial hydrolytic enzymes degrading extracellular components. Toxicon 2001; 39: 1769.
43. Matsushita O, Jung CM, Minami J, et al. A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase. J Biol Chem 1998; 273: 3643.
44. Matsushita O, KoideT, Kobayashi R, et al. Substrate recognition by the collagen-binding domain of Clostridium histolyticum class I collage-nase. J Biol Chem 2001; 276: 8761.
45. French MF, Mookhtiar KA, Van Wart HE. Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: Complementary digestion patterns. Biochemistry 1987; 26: 681.
46. Wolters GH, Vos-Scheperkeuter GH, Lin HC, et al. Different roles of class I and class II Clostridium histolyticum collagenase in rat pancreatic islet isolation. Diabetes 1995; 44: 227.
47. Brandhorst H, Raemsch-Guenther N, Raemsch R. The ratio between collagenase class I and class II influences the efficient islet release from the rat pancreas. Transplantation 2008; 85: 456.
48. Kin T, Zhai X, O'Gorman D, et al. Detrimental effect of excessive col-lagenase classIIonhuman islet isolation outcome.Transpl Int2008; 21: 1059.
49. Seifter S, Harper E. Collagenases. Methods Enzymol 1970; 19: 613.
50. Matsubara H. Thermolysin. Methods Enzymol 1970; 19: 642.
51. Griffin PJ, Fogarty WM. Physiochemical properties of the native, zinc-and manganese-prepared metalloprotease of Bacillus polymyxa. Appl Microbiol 1973; 26: 191.
52. Sparrow LG, McQuade AB. Isolation by affinity chromatography of neutral proteinase from Clostridium histolyticum.Biochim Biophys Acta 1973; 302: 90.
53. Mitchell W, Harrington W. Clostripain. Methods Enzymol 1970; 19: 635.
54. Kerr-Conte J, Vandewalle B, Moerman E, et al. Upgrading pretrans-plant human islet culture technology requires human serum combined with media renewal. Transplantation 2010; 89: 1154.
55. Roberts RC. Protease inhibitors of human plasma. Alpha-2-macroglobulin. J Med 1985; 16: 129.
56. Traverso LW, Abou-Zamzam AM. Activation of pancreatic proteolytic enzymes by commercial collagenases. Transplantation 1978; 25: 226.
57. Heiser A, Ulrichs K, Muller-Ruchholtz W. Isolation of porcine pancreatic islets: Low trypsin activity during the isolation procedure guarantees reproducible high islet yields. J Clin Lab Anal 1994; 8: 407.
58. Basir I, van der Burg MP, Scheringa M, et al. Improved outcome of pig islet isolation by Pefabloc inhibition of trypsin. Transplant Proc 1997; 29: 1939.
59. White SA, Djaballah H, Hughes DP, et al. A preliminary study of the activation of endogenous pancreatic exocrine enzymes during automated porcine islet isolation. Cell Transplant 1999; 8: 265.
60. Lakey JR, Helms LM, Kin T, et al. Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation 2001; 72: 565.
61. Rose NL, Palcic MM, Helms LM, etal. Evaluation ofPefabloc asaserine protease inhibitor during human-islet isolation. Transplantation 2003; 75: 462.
62. O'Gorman D, Kin T, Imes S, et al. Comparison of human islet isolation outcomes using a new mammalian tissue-free enzyme versus collage-nase NB-1. Transplantation 2010; 90: 255.
63. Kin T, O'Gorman D, Senior P, et al. Experience of islet isolation without neutral protease supplementation. Islets 2010; 2: 1.
64. Mitchell WM. The contamination of purified collagenase preparations by clostridiopeptidase B (clostripain): The potential effect on studies utilizing collagenase as a highly specific structural tool. John Hopkins Med J 1970; 127: 192.
65. Wünsch E, Heidrich HG. Zur quantitativen bestimmung der kollag-enase. Hoppe-Seyler's Z Physiol Chem 1963; 333: 149.
66. McCarthy RC, Spurlin B, Wright MJ, et al. Development and characterization of a collagen degradation assay to assess purified collagenase used in islet isolation. Transplant Proc 2008; 40: 339.
67. KinT, ZhaiX, Murdoch TB, etal. Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme. Am J Transplant 2007; 7: 1233.
68. Mandl I, MacLennan JD, Howes EL. Isolation and characterization of proteinase and collagenase from Cl. histolyticum. J Clin Invest 1953; 32: 1323.
69. Hefley TJ. Utilization of FPLC-purified bacterial collagenase for the isolation of cells from bone. J Bone Miner Res 1987; 2: 505.
70. Balamurugan AN, Breite AG, Anazawa T, et al. Successful human islet isolation and transplantation indicating the importance of class 1 col-lagenase and collagen degradation activity assay. Transplantation 2010; 89: 954.
71. Antonioli B, Fermo I, Cainarca S, et al. Characterization of collagenase blend enzymes for human islet transplantation. Transplantation 2007; 84: 568.
72. Bond MD, Van Wart HE. Characterization of the individual collag-enases from Clostridium histolyticum. Biochemistry 1984; 23: 3085.
73. Rawlings ND, Barrett AJ, Bateman A. MEROPS: The peptidase database. Nucleic Acids Res 2010; 38: D227.
74. Lin Y, Means GE, Feeney RE. The action of proteolytic enzymes on N, N-dimethyl proteins. Basis for a microassay for proteolytic enzymes. J Biol Chem 1969; 244: 789.
75. Breite AG, Dwulet FE, McCarthy RC. Tissue dissociation enzyme neutral protease assessment. Transplant Proc 2010; 42: 2052.
76. Lakey JR, Warnock GL, Rajotte RV, etal. Variablesinorgan donors that affect the recovery of human islets of Langerhans. Transplantation 1996; 61: 1047.
77. Nano R, Clissi B, Melzi R, et al. Islet isolation for allotransplanta-tion: Variables associated with successful islet yield and graft function. Diabetologia 2005; 48: 906.
78. O'Gorman D, Kin T, Murdoch T. The standardization of pancreatic donors for islet isolation. Transplant Proc 2005; 37: 1309.
79. Hanley SC, Paraskevas S, Rosenberg L. Donor and isolation variables predicting human islet isolation success. Transplantation 2008; 85: 950.
80. Kaddis JS, Danobeitia JS, Niland JC, et al. Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes. Am J Transplant 2010; 10: 646.
81. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. New Eng J Med 2006; 355: 1318.
82. Van Wart HE, Steinbrink DR. A continuous spectrophotometric assay for Clostridium histolyticum collagenase. Anal Biochem 1981; 113: 356.
83. Mandl I, Keller S, Manahan J. Multiplicity of Clostridium histolytcum collagenases. Biochemistry 1964; 3: 1737.
84. Chavira R, Burnett TJ, Hageman JH. Assaying proteases with azocoll. Anal Biochem 1984; 136: 446.
85. Bucher P, Mathe Z, Morel P, et al. Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation 2005; 79: 91.
86. Twining SS. Fluorescein isothiocyanate-labeled casein assay for proteo-lytic enzymes. Anal Biochem 1984; 143: 30.
87. Sigma neutral protease assay. Available at: http://www.sigmaaldrich.com/ etc/medialib/docs/Sigma/Enzyme-Assay/p1512enz.Par.0001.File.tmp/p1512enz.pdf. Accessed August 23, 2010.
88. Worthington neutral protease assay. Available at: http://www.worthington- biochem.com/DISP/assay.html. Accessed August 23, 2010.
89. Wilson JJ, Matsushita O, Okabe A, et al. A bacterial collagen-binidng domain with novel calcium-binding motif controls domain orientation. EMBO J 2003; 8: 1743.